Enabling drug delivery
For
therapeutic situations requiring rapid absorption, noninvasive delivery
and greater bioavailability, CIMA offers two innovative transmucosal
delivery technologies.
Drugs that
are absorbed directly through the oral mucosa bypass the
gastrointestinal tract, reducing the first-pass effect of the liver.
This may result in greater drug uptake and more rapid systemic exposure.